home / stock / nrbo / nrbo short
Short Information | NeuroBo Pharmaceuticals Inc. (NASDAQ:NRBO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 74,576 |
Total Actual Volume | 557,656 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 3,729 |
Average Short Percentage | 13.52% |
Is there a NRBO Short Squeeze or Breakout about to happen?
See the NRBO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $3.06 | $3.14 | $3.14 | $3 | 16,907 | 235 | 1.39% |
04-24-2024 | $2.99 | $3.1 | $3.4999 | $2.99 | 39,253 | 6,388 | 16.27% |
04-23-2024 | $3.1 | $3.02 | $3.19 | $2.99 | 42,194 | 2,417 | 5.73% |
04-22-2024 | $3.26 | $3.12 | $3.3 | $3.08 | 23,389 | 1,625 | 6.95% |
04-19-2024 | $3.49 | $3.37 | $3.49 | $3.26 | 20,562 | 1,538 | 7.48% |
04-18-2024 | $3.59 | $3.44 | $3.59 | $3.3534 | 22,788 | 3,787 | 16.62% |
04-17-2024 | $3.69 | $3.46 | $3.69 | $3.46 | 11,485 | 2,137 | 18.61% |
04-16-2024 | $3.615 | $3.4 | $3.615 | $3.33 | 12,946 | 1,285 | 9.93% |
04-15-2024 | $3.61 | $3.53 | $3.73 | $3.49 | 22,921 | 1,691 | 7.38% |
04-12-2024 | $3.58 | $3.61 | $3.95 | $3.58 | 75,652 | 11,746 | 15.53% |
04-11-2024 | $3.69 | $3.58 | $3.69 | $3.56 | 14,708 | 1,789 | 12.16% |
04-10-2024 | $3.55 | $3.56 | $3.6648 | $3.5 | 13,047 | 2,034 | 15.59% |
04-09-2024 | $3.93 | $3.53 | $3.93 | $3.47 | 47,568 | 5,862 | 12.32% |
04-08-2024 | $3.8 | $3.97 | $3.97 | $3.7701 | 13,359 | 4,049 | 30.31% |
04-05-2024 | $3.94 | $3.88 | $3.94 | $3.75 | 24,657 | 4,616 | 18.72% |
04-04-2024 | $3.9 | $3.89 | $4.04 | $3.82 | 24,760 | 8,892 | 35.91% |
04-03-2024 | $3.93 | $3.89 | $4.0699 | $3.8001 | 14,445 | 1,977 | 13.69% |
04-02-2024 | $4.05 | $3.93 | $4.12 | $3.85 | 27,715 | 479 | 1.73% |
04-01-2024 | $4.12 | $4.06 | $4.33 | $3.8 | 53,730 | 10,170 | 18.93% |
03-28-2024 | $4.24 | $4.09 | $4.39 | $4.07 | 35,570 | 1,859 | 5.23% |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Phase 1 Clinical Trial Timelines Significantly Accelerated Top-Line Data Readout from Single Ascending Dose Part 1 Now Expected in the ...
NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH PR Newswire Full Data Readout Expected in the Second Half of 2024 CAMBRIDGE, Mass. , April 1 , 2024 /PRNewswire/ -- Neur...
NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update PR Newswire Received First Site Institutional Review Board (IRB) Approval to Proceed With the Phase 1 Trial of DA-1726 in Obesity Phase 1 Trial of DA-1726 Expected to ...